• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


H&T Presspart Low GWP Banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

2012 AAPS annual meeting

The Monday afternoon poster session featured several dozen posters on the topic of nasal and pulmonary formulation, plus several OINDP posters in the regulatory section. Most of the other sessions featured smaller numbers of OINDP-related posters. The AAPS has posted abstracts for posters and papers on its site.

Only a few sessions at the meeting were of interest to OINDP specialists, especially two symposia devoted to analytical techniques. The first, a sunrise session on Wednesday morning titled “Defining Critical Quality Attributes for Combination Products” and the second, on Thursday morning, was titled “Correlating In Vitro and In Vivo Lung Deposition of Pulmonary Formulation: Pharmacokinetic and and Regulatory Perspective.”

Hovione’s new Xcaps inhaler

Hugh Smythe of the University of Texas, Austin, also presented a paper in a mini-symposium titled, “Innovative Emerging Technologies in Alternative Dosage Form Designs: The Eye Nose the Skin” that took place at the same time as the symposium on IVIVC.

Few of the inhalation and nasal related businesses exhibiting at AAPS introduced any new products or services at the meeting. One exception was Hovione, which was showing its new Xcaps inhaler, which has not yet launched officially. The company announced in 2011 that it was filing a patent for Xcaps, which has only two components in addition to the dust cover.

FPS benchtop jet mill

FPS benchtop jet mill

DEC benchtop micronizer

Some inhalation researchers at the meeting took note of several benchtop micronizers with ultra-low capacities exhibited by several different companies. Dec was showing its MicroJet mill, which comes in a range of sizes with a capacity as low as 100 mg and which includes a cyclone for collection of the micronized powder and filtration. FPS was exhibiting its PilotMill-Zero, which it advertises as the world’s smallest fluid jet mill, with a capacity of 10 mg.

Contract manufacturer PharmaForm, which offers formulation and manufacturing services for nasal sprays and inhalation powders among other dosage forms, chose AAPS to announce its move to San Diego.

View more photos from the meeting.

Share
« Previous Page 1 2

published on October 22, 2012

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Bespak Leading the Green Transition banner
    © 2025 OINDPnews